リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

リケラボ 全国の大学リポジトリにある学位論文・教授論文を一括検索するならリケラボ論文検索大学・研究所にある論文を検索できる

大学・研究所にある論文を検索できる 「Myelodysplastic syndrome with trisomy 8 presenting periodic fever and multiple MEFV gene variants outside exon 10: a case report」の論文概要。リケラボ論文検索は、全国の大学リポジトリにある学位論文・教授論文を一括検索できる論文検索サービスです。

コピーが完了しました

URLをコピーしました

論文の公開元へ論文の公開元へ
書き出し

Myelodysplastic syndrome with trisomy 8 presenting periodic fever and multiple MEFV gene variants outside exon 10: a case report

Takahashi, Noriyuki Hanajiri, Ryo Suzuki, Masashi Anan, Chise Inagaki, Atsushi Kishida, Dai Ozawa, Shohei Kohri, Sho Kamiya, Nobuhide Sato, Motoki Sato, Juichi 名古屋大学

2023.02

概要

Studies have shown that cellular genetic abnormalities (eg, chromosomal abnormalities
and somatic variants) in patients with myelodysplastic syndrome (MDS) are associated with
autoinflammatory disease.1,2 Autoinflammatory disease is characterized by the dysregulation
of innate immunity, in which myeloid lineage cells (ie, neutrophils) and monocyte lineage
cells (ie, macrophages) are important cellular players.1,2 The discovery of a novel adult-onset
autoinflammatory disease associated with MDS has indicated the importance of characterizing
the autoinflammatory disease in MDS cases.2,3 Among 134 patients with MDS, 61 (46.3%)
had an autoinflammatory condition, including recurrent fever, polymyalgia, arthralgia, arthritis,
erythema, and pleural effusion.1 Trisomy 8 is a common chromosomal abnormality in patients
with MDS, occurring in approximately 10% of cases.4 Trisomy 8 in patients with MDS causes
autoinflammatory conditions, especially Behçet’s disease-like symptoms (eg, fever, abdominal
pain, and ulcerative intestinal lesions).5-9 Only a few other inflammatory conditions are related to
MDS trisomy 8: pyoderma gangrenosum, Sweet’s syndrome, pulmonary alveolar proteinosis, and
inflammatory arthritis.10 Although some reports have suggested that trisomy 8 in patients with
MDS leads to periodic fever and erythema nodosum without intestinal mucosal damage, these
cases are currently recognized as being within the category of Behçet’s disease-like symptoms.8,9
Gain-of-function variants in pyrin, a product of the MEFV gene, cause familial Mediterranean
fever (FMF).11 FMF is the most common autoinflammatory disease, affecting 120,000 people
worldwide.11 The Tel-Hashomer criteria described by Livneh et al are widely used to diagnose
FMF.12 They include five major criteria and four minor criteria. The five major criteria are: 1)
peritonitis; 2) pleuritis or pericarditis; 3) monoarthritis; 4) fever alone; and 5) incomplete abdominal attacks differing from the typical attacks. The four minor criteria are: 1) and 2) incomplete
attacks differing from the typical attacks, involving the chest or joints, respectively; 3) exertional
leg pain; and 4) favorable response to colchicine. To diagnose FMF, one or more major criteria
or two or more minor criteria should be met. Typical symptoms of FMF, including pleuritis and
peritonitis, are related to variants in exon 10 of the MEFV gene.13,14 Conversely, other MEFV
variants (outside exon 10), which are more common in Japanese individuals, produce atypical
symptoms, including myalgia and erythema.13-15 Tanaka et al reported a patient with MDS who
had trisomy 8 and an MEFV variant (outside exon 10) that manifested as periodic fevers and
intestinal Behçet’s disease-like symptoms.16 However, to the best of our knowledge, no reports
have been published describing MDS trisomy 8 presenting with periodic fever involving multiple
MEFV variants (outside exon 10) with a suspicion of autoinflammatory conditions other than
Behçet’s disease-like symptoms. Here, we describe a patient with MDS and trisomy 8 exhibiting
multiple MEFV variants outside exon 10, although his symptoms such as periodic fever, as well
as chest/abdominal pain, myalgia, and erythema, did not fulfill the diagnostic criteria of FMF. ...

この論文で使われている画像

関連論文

参考文献

1 Watad A, Kacar M, Bragazzi NL, et al. Somatic mutations and the risk of undifferentiated autoinflammatory disease in MDS: an under-recognized but prognostically important complication. Front Immunol.

2021;12:610019. doi:10.3389/fimmu.2021.610019.

2 Oganesyan A, Hakobyan Y, Terrier B, Georgin-Lavialle S, Mekinian A. Looking beyond VEXAS: coexistence

of undifferentiated systemic autoinflammatory disease and myelodysplastic syndrome. Semin Hematol.

2021;58(4):247–253. doi:10.1053/j.seminhematol.2021.10.003.

3 Beck DB, Ferrada MA, Sikora KA, et al. Somatic mutations in UBA1 and severe adult-onset autoinflammatory disease. N Engl J Med. 2020;383(27):2628–2638. doi:10.1056/NEJMoa2026834.

4 Tefferi A, Vardiman JW. Myelodysplastic syndromes. N Engl J Med. 2009;361(19):1872–1885. doi:10.1056/

NEJMra0902908.

5 Lin YC, Liang TH, Chang HN, Lin JS, Lin HY. Behçet disease associated with myelodysplastic syndrome.

J Clin Rheumatol. 2008;14(3):169–174. doi:10.1097/RHU.0b013e3181776bde.

6 Shen Y, Ma HF, Luo D, Cai JF, Zou J, Guan JL. High incidence of gastrointestinal ulceration and

cytogenetic aberration of trisomy 8 as typical features of Behçet’s disease associated with myelodysplastic

syndrome: a series of 16 consecutive Chinese patients from the Shanghai Behçet’s disease database and

comparison with the literature. Biomed Res Int. 2018;2018:8535091. doi:10.1155/2018/8535091.

7 Wesner N, Drevon L, Guedon A, et al. Inflammatory disorders associated with trisomy 8-myelodysplastic

syndromes: French retrospective case-control study. Eur J Haematol. 2019;102(1):63–69. doi:10.1111/

ejh.13174.

8 Esatoglu SN, Hatemi G, Salihoglu A, Hatemi I, Soysal T, Celik AF. A reappraisal of the association between

Behçet’s disease, myelodysplastic syndrome and the presence of trisomy 8: a systematic literature review.

Clin Exp Rheumatol. 2015;33(6 Suppl 94):S145-S151.

9 Fujimura T, Yukawa N, Nakashima R, et al. Periodic fever and erythema nodosum associated with MDS

with trisomy 8: report of two cases and review of the literature. Mod Rheumatol. 2010;20(4):413–419.

doi:10.1007/s10165-010-0291-9.

10 Jachiet V, Fenaux P, Sevoyan A, et al. Inflammatory and immune disorders associated with myelodysplastic

syndromes. Hemato. 2021;2(2):329–346. doi:10.3390/hemato2020019.

11 Padeh S, Bilginer Y, Ozen S. Familial Mediterranean Fever. In: Hashkes PJ, Laxer RM, Simon A, eds.

Textbook of Autoinflammation. Switzerland: Springer Nature; 2019:chap 16. doi:10.1007/978-3-319-98605-0.

12 Livneh A, Langevitz P, Zemer D, et al. Criteria for the diagnosis of familial Mediterranean fever. Arthritis

Rheum. 1997;40(10):1879–1885. doi:10.1002/art.1780401023.

13 Migita K, Uehara R, Nakamura Y, et al. Familial Mediterranean fever in Japan. Medicine (Baltimore).

2012;91(6):337–343. doi:10.1097/MD.0b013e318277cf75.

14 Migita K, Agematsu K, Yazaki M, et al. Familial Mediterranean fever: genotype-phenotype correlations in

Japanese patients. Medicine (Baltimore). 2014;93(3):158–164. doi:10.1097/MD.0000000000000029.

15 Kishida D, Nakamura A, Yazaki M, Tsuchiya-Suzuki A, Matsuda M, Ikeda S. Genotype-phenotype

correlation in Japanese patients with familial Mediterranean fever: differences in genotype and clinical

features between Japanese and Mediterranean populations. Arthritis Res Ther. 2014;16(5):439. doi:10.1186/

s13075-014-0439-7.

16 Tanaka N, Sakuraba H, Hiraga H, et al. Long-term maintenance of the mucosal healing induced by

azacitidine therapy in a patient with intestinal Behçet’s-like disease accompanied with myelodysplastic

syndrome involving trisomy 8. Immunol Med. 2019;42(3):135–141. doi:10.1080/25785826.2019.1687251.

Nagoya J. Med. Sci. 85. 195–203, 2023

202

doi:10.18999/nagjms.85.1.195

Trisomy 8 MDS with multiple MEFV variants

17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 Sarrauste de Menthière C, Terriere S, Pugnère D, Ruiz M, Demaille J, Touitou I. INFEVERS: the registry for

FMF and hereditary inflammatory disorders mutations. Nucleic Acids Res. 2003;31(1):282–285. doi:10.1093/

nar/gkg031.

Vardiman JW, Thiele J, Arber DA, et al. The 2008 revision of the World Health Organization (WHO)

classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood.

2009;114(5):937–951. doi:10.1182/blood-2009-03-209262.

Abbara S, Grateau G, Ducharme-Bénard S, Saadoun D, Georgin-Lavialle S. Association of vasculitis and

familial Mediterranean fever. Front Immunol. 2019;10:763. doi:10.3389/fimmu.2019.00763.

Touitou I, Magne X, Molinari N, et al. MEFV mutations in Behçet’s disease. Hum Mutat. 2000;16(3):271–

272. doi:10.1002/1098-1004(200009)16:3<271::AID-HUMU16>3.0.CO;2-A.

Ayaz NA, Ozen S, Bilginer Y, et al. MEFV mutations in systemic onset juvenile idiopathic arthritis.

Rheumatology (Oxford). 2009;48(1):23–25. doi:10.1093/rheumatology/ken409.

Jo T, Horio K, Migita K. Sweet’s syndrome in patients with MDS and MEFV mutations. N Engl J Med.

2015;372(7):686–688. doi:10.1056/NEJMc1412998.

Alberts B, Johnson A, Lewis J, et al. Chapter 15 Cell Signaling. In: Molecular Biology of the Cell. Sixth

ed. New York: Garland Science; 2017:813–888.

Lorente-Sorolla C, Netea MG, Ballestar E. Epigenetics in Autoinflammation. In: Hashkes PJ, Laxer RM,

Simon A, eds. Textbook of Autoinflammation. Switzerland: Springer Nature; 2019:chap 3. doi:10.1007/9783-319-98605-0.

Glenthøj A, Ørskov AD, Hansen JW, Hadrup SR, O’Connell C, Grønbæk K. Immune mechanisms in

myelodysplastic syndrome. Int J Mol Sci. 2016;17(6):944. doi:10.3390/ijms17060944.

Vander Pluym JH, O’Sullivan J, Andrew G, Bolduc FV. Genomic characterization of chromosome 8

pericentric trisomy. Clin Case Rep. 2015;3(7):570–577. doi:10.1002/ccr3.234.

Schmid JA, Birbach A. IkB kinase b (IKKb/IKK2/IKBKB) — A key molecule in signaling to the transcription

factor NF-kB. Cytokine Growth Factor Rev. 2008;19(2):157–165. doi:10.1016/j.cytogfr.2008.01.006.

Chae JJ, Wood G, Richard K, et al. The familial Mediterranean fever protein, pyrin, is cleaved by caspase-1 and activates NF-kB through its N-terminal fragment. Blood. 2008;112(5):1794–1803. doi:10.1182/

blood-2008-01-134932.

Fujikura K. Global epidemiology of familial Mediterranean fever mutations using population exome

sequences. Mol Genet Genom Med. 2015;3(4):272–282. doi:10.1002/mgg3.140.

Bernot A, Da Silva C, Petit JL, et al. Non-founder mutations in the MEFV gene establish this gene as

the cause of familial Mediterranean fever (FMF). Hum Mol Genet. 1998;7(8):1317–1325. doi:10.1093/

hmg/7.8.1317.

Fujimoto K, Hidaka Y, Koga T, et al. MEFV E148Q variant is more associated with familial Mediterranean

fever when combined with other non-exon 10 MEFV variants in Japanese patients with recurrent fever.

Mod Rheumatol. 2021;31(6):1208–1214. doi:10.1080/14397595.2021.1880534.

Miyoshi T, Yamashita K, Ohno T, et al. Familial Mediterranean fever gene as a possible modifier of Sweet

syndrome with chronic myelogenous leukemia. Acta Haematol. 2008;120(1):57–62. doi:10.1159/000158578.

Sugie M, Ouchi T, Kishida D, Yasaki S. Atypical type of familial Mediterranean fever: an underdiagnosed

cause of chronic aseptic meningitis. Neurol Clin Neurosci. 2018;6(6):191–193. doi:10.1111/ncn3.12232.

Kimura K, Mizooka M, Migita K, et al. Five cases of familial Mediterranean fever in Japan: the relationship

with MEFV mutations. Intern Med. 2018;57(16):2425–2429. doi:10.2169/internalmedicine.0057-17.

Sato T, Takezaki S, Goto T, et al. Atypical familial Mediterranean fever in a Japanese boy with heterozygous

MEFV p. Ser503Cys exon 5 variant. Case Rep Pediatr. 2021;2021:6650226. doi:10.1155/2021/6650226.

Shinar Y, Tohami T, Livneh A, et al. Acquired familial Mediterranean fever associated with a somatic

MEFV mutation in a patient with JAK2 associated post-polycythemia myelofibrosis. Orphanet J Rare Dis.

2015;10:86. doi:10.1186/s13023-015-0298-6.

Komrokji RS, Kulasekararaj A, Al Ali NH, et al. Autoimmune diseases and myelodysplastic syndromes.

Am J Hematol. 2016;91(5):E280-E283. doi:10.1002/ajh.24333.

References End

Nagoya J. Med. Sci. 85. 195–203, 2023

203

doi:10.18999/nagjms.85.1.195

...

参考文献をもっと見る

全国の大学の
卒論・修論・学位論文

一発検索!

この論文の関連論文を見る